CARMA1, BCL-10 and MALT1 in lymphocyte development and activation
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BCL10 is an immune signaling adaptor mostly expressed in lymphocytes. It has a key role in lymphocyte activation through the nuclear factor-kappa B pathway28.”
From Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation (2024) · cites this paper as [28]
Citations
Cites
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Signal transduction by lymphocyte antigen receptors
Weiss, A., & Littman, D. R. (1994) · Cell · doi:10.1016/0092-8674(94)90334-4 · Cited by 2,089 · cited 1×
“It is well established that antigen-receptor triggering leads to a marked and rapid induction of tyrosine phosphorylation through the activation of SRC- and SYK-family kinase”
BackgroundThemes and variations on ubiquitylation
Weissman, A. M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056563 · Cited by 1,482
The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
Roy, N. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.6914 · Cited by 1,301 · cited 1×
“Alternatively, the BIR-domain-containing amino terminus of the cIAP–MALT1 fusion protein might confer anti-apoptotic activity by directly inhibiting caspase”
BackgroundHirschfeld, M., Ma, Y., Weis, J. H., Vogel, S. N., & Weis, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.618 · Cited by 1,153
Uren (2000) · Molecular Cell · Cited by 965
The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling
Karin, M., & Delhase, M. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0210 · Cited by 955
T Lymphocyte Costimulation Mediated by Reorganization of Membrane Microdomains
Viola, A., Schroeder, S., Sakakibara, Y., & Lanzavecchia, A. (1999) · Science · doi:10.1126/science.283.5402.680 · Cited by 938 · cited 1×
“cgi?l=7409">VAV1 by the TCR and CD28, as well as recruitment and enrichment of lipid rafts in the T cell–antigen-presenting cell (APC) contact are”
BackgroundPKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L., et al. (2000) · Nature · doi:10.1038/35006090 · Cited by 892 · cited 1×
“cgi?l=5579">PKC-β have a key role in TCR- and BCR-induced NF-κB activation, respectivel”
BackgroundMartin, F., & Kearney, J. F. (2002) · Nature Reviews Immunology · doi:10.1038/nri799 · Cited by 860
Cited by
Items 201–300 of 396
The PI3K p110δ controls T-cell development, differentiation and regulation
Patton, D. T., Garçon, F., & Okkenhaug, K. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350167 · Cited by 31
Nakagawa, M., Seto, M., & Hosokawa, Y. (2006) · Leukemia · doi:10.1038/sj.leu.2404192 · Cited by 31
Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation
Ginster, S., Bardet, M., Unterreiner, A., Malinverni, C., Renner, F., Lam, S., Freuler, F., Gerrits, B., Voshol, J., Calzascia, T., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169026 · Cited by 30
Bhattacharyya, S., Borthakur, A., Anbazhagan, A. N., Katyal, S., Dudeja, P. K., & Tobacman, J. K. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00071.2011 · Cited by 30
“The molecular structure and function of the CBM complex in myeloid cells have been presented in several reports (20, 23, 29, 31, 34, 35).”
BackgroundExploration of 2-benzylbenzimidazole scaffold as novel inhibitor of NF-κB
Boggu, P. R., Eeda, V., Manickam, M., Kwak, D., Kim, Y. S., & Jung, S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.012 · Cited by 30
IκBNS Regulates Murine Th17 Differentiation during Gut Inflammation and Infection
Annemann, M., Wang, Z., Plaza‐Sirvent, C., Glauben, R., Schuster, M., Sander, F. E., Mamareli, P., Kühl, A. A., Siegmund, B., Lochner, M., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401964 · Cited by 36
Genetic drivers of NF-κB deregulation in diffuse large B-cell lymphoma
Pasqualucci, L., & Zhang, B. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.08.001 · Cited by 34
Protein kinase Cθ controls type 2 innate lymphoid cell and TH2 responses to house dust mite allergen
Madouri, F., Chenuet, P., Beuraud, C., Fauconnier, L., Marchiol, T., Rouxel, N., Ledru, A., Gallerand, M., Lombardi, V., Mascarell, L., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.044 · Cited by 30
LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation
Morimoto, K., Baba, Y., Shinohara, H., Kang, S., Nojima, S., Kimura, T., Ito, D., Yoshida, Y., Maeda, Y., Sarashina-Kida, H., et al. (2016) · Scientific Reports · doi:10.1038/srep25738 · Cited by 28
Moreno‐García, M. E., Sommer, K., Haftmann, C., Sontheimer, C., Andrews, S. F., & Rawlings, D. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902438 · Cited by 31
“nal region highly related to the MAGUK family of proteins (17).”
BackgroundHelical assembly of the CARD9 CARD
Holliday, M., Rohou, A. L., Arthur, C. P., Dueber, E. C., & Fairbrother, W. J. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6n2p/pdb · Cited by 28
Molecular Pathways: Targeting MALT1 Paracaspase Activity in Lymphoma
Fontán, L., & Melnick, A. M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3869 · Cited by 29
Phospholipase Cγ2 Mediates RANKL-stimulated Lymph Node Organogenesis and Osteoclastogenesis
Chen, Y., Wang, X., Di, L., Fu, G., Chen, Y., Bai, L., Liu, J., Feng, X., McDonald, J. M., Michalek, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802493200 · Cited by 27
CARMA3 Is Critical for the Initiation of Allergic Airway Inflammation
Causton, B., Ramadas, R. A., Cho, J. L., Jones, K., Pardo–Saganta, A., Rajagopal, J., Xavier, R. J., & Medoff, B. D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402983 · Cited by 27
“that contain a CARD, a coiled-coil domain, a linker, a PDZ domain, a SH3 domain, and a C-terminal membrane-associated guanylate kinase domain (48).”
BackgroundCADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation
Hunte, R., Alonso, P., Thomas, R., Bazile, C. A., Ramos, J. C., van der Weyden, L., Domínguez‐Bendala, J., Khan, W. N., & Shembade, N. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006968 · Cited by 30
B Cell Lymphoma 10 Is Essential for FcεR-Mediated Degranulation and IL-6 Production in Mast Cells
Chen, Y., Pappu, B. P., Zeng, H., Xue, L., Morris, S. W., Lin, X., Wen, R., & Wang, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.49 · Cited by 30
“Bcl10, along with CARMA1 and MALT1, forms a three-component complex, which couples PKC to IKK upon AgR engagement (36, 37).”
BackgroundMethodInfluentialPark, K., Lee, J.-H., Chun-yeon, C. H. O. I., Liu, K., Seog, D., Kim, Y.-H., Kim, D., Yun, C., & Yea, S. S. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.05.015 · Cited by 26
Hosokawa, Y., Suzuki, H., Nakagawa, M., Lee, T. H., & Seto, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.058 · Cited by 25
Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase
Steinhardt, J. J., Peroutka, R. J., Mazan-Mamczarz, K., Chen, Q., Houng, S., Robles, C., Barth, R. N., DuBose, J. J., Bruns, B. R., Tesoriero, R., et al. (2014) · Blood · doi:10.1182/blood-2014-07-589689 · Cited by 29
Briones, J., Moga, E., Espinosa, Í., Vergara, C., Álvarez, E., Villa, J., Bordes, R., Delgado, J., Prat, J., & Sierra, J. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03250.x · Cited by 26
Alternative UPS drug targets upstream the 26S proteasome
Hjerpe, R., & Rodríguez, M. S. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.021 · Cited by 28
Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?
Amin, A. D., Peters, T. L., Li, L., Rajan, S. S., Choudhari, R., Puvvada, S. D., & Schatz, J. H. (2017) · Molecular Case Studies · doi:10.1101/mcs.a001719 · Cited by 30
Roberts, H., Lopopolo, M., Pagnamenta, A. T., Sharma, E., Parkes, D., Lonie, L. J., Freeman, C., Knight, S. J. L., Lunter, G. A., Dreau, H. M.-P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85354-8 · Cited by 30
Approaches to Establishing Tolerance in Immune Mediated Diseases
Huffaker, M. F., Sanda, S., Chandran, S., Chung, S. A., Clair, E. W. S., Nepom, G. T., & Smilek, D. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.744804 · Cited by 26
Chan, K.-K., Shen, L., Au, W., Yuen, H., Wong, K., Guo, T., Wong, M. L. Y., Shimizu, N., Tsuchiyama, J., Kwong, Y., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2699 · Cited by 23
Knittel, G., Liedgens, P., Korovkina, D., Pallasch, C. P., & Reinhardt, H. C. (2016) · European Journal Of Haematology · doi:10.1111/ejh.12792 · Cited by 27
“a C-terminal MAGUK domain through a linker sequence (57).”
BackgroundGenetic analysis of B cell signaling
Shinohara, H., & Kurosaki, T. (2006) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-4896-8_10 · Cited by 23
Nagy, Z. S., Rui, H., Stepkowski, S. M., Karras, J. G., & Kirken, R. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5032 · Cited by 25
“Because Bcl10, Traf2, and Traf5 act as upstream activators of NF- B and regulate the activity of the I B kinase complex (61, 65), one possible model to explain these findings is that STAT5 depletion reduces the expression of these effectors and consequent NF- B activation that is important for cell survival.”
BackgroundHuman BCL10 Deficiency due to Homozygosity for a Rare Allele
Rym, A. M. V. D., Taur, P. D., Martínez‐Barricarte, R., Lorenzo, L., Puel, A., Navarro, P. G., Pandrowala, A. A., Gowri, V., Safa, A., Toledano, V., et al. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00760-3 · Cited by 22
Characterization of a major colon cancer susceptibility locus (Ccs3) on mouse chromosome 3
Meunier, C., Cai, J., Fortin, A., Kwan, T., Marquis, J. F., Turbide, C., Kraak, L. V. D., Jothy, S., Beauchemin, N., & Gros, P. (2009) · Oncogene · doi:10.1038/onc.2009.369 · Cited by 24
“Bcl10 (145.6Mb) is a signaling molecule and caspase regulator that has proapoptotic activity important for the development and activation of B and T lymphocytes (Thome, 2004).”
BackgroundSo, T., & Croft, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00133 · Cited by 24
“CARMA1 [caspase-recruitment domain (CARD)-membraneassociated guanylate kinase (MAGUK) protein 1] has been shown to control this NF-κB1 activation by forming a complex with B cell lymphoma 10 (BCL10), and mucosa-associated-lymphoid-tissue lymphoma-translocation gene 1 (MALT1), termed CBM (Gaide et al., 2002; Wang et al…”
MethodExpression profiling reveals specific gene expression signatures in gastric MALT lymphomas
Huynh, M. Q., Wacker, H., Wündisch, T., Sohlbach, K., Kim, T. D., Krause, M., Stabla, K., Roth, P., Fischbach, W., Stolte, M., et al. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802007734 · Cited by 22
Conroy, B. D., Herek, T. A., Shew, T. D., Latner, M., Larson, J. J., Allen, L., Davis, P. H., Helikar, T., & Cutucache, C. E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00599 · Cited by 21
c‐FLIPS reduces activation of caspase and NF‐κB pathways and decreases T cell survival
Hinshaw-Makepeace, J. A., Huston, G. E., Fortner, K. A., Russell, J. Q., Holoch, D., Swain, S. L., & Budd, R. C. (2007) · European Journal of Immunology · doi:10.1002/eji.200636956 · Cited by 25
“4B), c-FLIPS T cells manifested reduced phosphorylation of IjBa and IKKa/ b following stimulation with anti-CD3/anti-CD28 (Fig.”
BackgroundInfluentialMolecular Architecture of Signal Complexes Regulating Immune Cell Function
Torgersen, K. M., Aandahl, E. M., & Taskén, K. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72843-6_14 · Cited by 20
Bcl10 can promote survival of antigen-stimulated B lymphocytes
Tian, M. T., González, G., Scheer, B., & DeFranco, A. L. (2005) · Blood · doi:10.1182/blood-2004-04-1248 · Cited by 22
Roche, M. I., Ramadas, R. A., & Medoff, B. D. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013007056 · Cited by 21
Burbach, B. J., Srivastava, R., Ingram, M. A. C., Mitchell, J. S., & Shimizu, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002950 · Cited by 20
MALT Lymphoma as a Model of Chronic Inflammation-Induced Gastric Tumor Development
Marcelis, L., Tousseyn, T., & Sagaert, X. (2019) · Current topics in microbiology and immunology · doi:10.1007/978-3-030-15138-6_4 · Cited by 23
Kuper-Hommel, M. J. J., & van Krieken, J. H. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.631157 · Cited by 20
Malt1 self‐cleavage is critical for regulatory T cell homeostasis and anti‐tumor immunity in mice
Baens, M., Stirparo, R., Lampi, Y., Verbeke, D., Vandepoel, R., Cools, J., Marynen, P., de Bock, C. E., & Bornschein, S. (2018) · European Journal of Immunology · doi:10.1002/eji.201847597 · Cited by 20
The role of serine/threonine kinases in T-cell activation
Matthews, S. A., & Cantrell, D. A. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.006 · Cited by 20
Regulation of Phospholipase C‐γ2 Networks in B Lymphocytes
Hikida, M., & Kurosaki, T. (2005) · Advances in immunology · doi:10.1016/s0065-2776(05)88003-4 · Cited by 24
Hayakawa, K., Formica, A. M., Zhou, Y., Ichikawa, D., Asano, M., Li, Y.-S., Shinton, S. A., Brill‐Dashoff, J., Núñez, G., & Hardy, R. R. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170497 · Cited by 18
“However, some FO B cells show autoreactivity, and mutations that handicap NF-κB activation induced by BCR signaling result in a decreased frequency of FO B cells, in particular IgMloIgD+ FO B cells, together with a severe reduction of B1 B and MZ B cells (Thome, 2004).”
BackgroundSynthesis and structure–activity relationship studies of MI-2 analogues as MALT1 inhibitors
Wu, G., Wang, H., Zhou, W., Zeng, B., Mo, W., Zhu, K., Liu, R., Zhou, J., Chen, C., & Chen, H. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.04.059 · Cited by 18
Molecular Dynamics of Co-signal Molecules in T-Cell Activation
Saito, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_5 · Cited by 18
Adaptors discriminate mast-cell cytokine production from eicosanoid production and degranulation
Rivera, J. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.04.001 · Cited by 18
BCL10 regulates RNF8/RNF168-mediated ubiquitination in the DNA damage response
Zhao, H., Zhu, M., Dou, G., Zhao, H., Zhu, B., Li, J., Liao, J., & Xu, X. (2014) · Cell Cycle · doi:10.4161/cc.28707 · Cited by 17
“BCL10 constitutively associates with MALT1 and forms a complex with CARMA1, namely CBM, facilitating the activation of the NFκB pathway in the cytosol.(30,37) We sought to determine if BCL10 in the nucleus requires MALT1 to execute its function in DSB signaling and repair.”
BackgroundB-cell receptors and heavy chain diseases: guilty by association?
Corcos, D., Osborn, M. J., & Matheson, L. S. (2011) · Blood · doi:10.1182/blood-2011-02-336164 · Cited by 17
Liu, Y., Song, R., Gao, Y., Li, Y., Wang, S., Liu, H.-Y., Wang, Y., Hu, Y.-H., & Shu, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.335463 · Cited by 17
The CBM signalosome: Potential therapeutic target for aggressive lymphoma?
Yang, C., David, L., Qiao, Q., Damko, E., & Wu, H. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.008 · Cited by 18
“As a direct target of PKCb/PKCu, the CBM complex is activated by PKCb/PKCu and recruited to the lipid raft immunological synapse, which subsequently recruits other downstream signaling components such as TRAF2/TRAF6, TAK1 (transforming growth factor-bactivated kinase 1) and TAB (TAK1 binding protein) to activate the i…”
InfluentialTsui, K.-H., Chang, K., Sung, H., Hsu, S.-Y., Lin, Y., Hou, C., Yang, P., Chen, C., Feng, T., & Juang, H. (2021) · Biomedicines · doi:10.3390/biomedicines9030250 · Cited by 19
CARMA1 Is Necessary for Optimal T Cell Responses in a Murine Model of Allergic Asthma
Ramadas, R. A., Roche, M. I., Moon, J. J., Ludwig, T. E., Xavier, R. J., & Medoff, B. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101348 · Cited by 19
“phenotype (CD4CD44) T cells without (2) or with (+) anti-CD3 and anti-”
BackgroundInfluentialYu, M., Chen, Y., He, Y., Podd, A., Fu, G., Wright, J. A., Kleiman, E., Khan, W. N., Wen, R., & Wang, D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102952 · Cited by 19
“1 (CD93; 13-5892), PE-conjugated anti-CD23 (12-0232), and PE-Cy7–conjugated streptavidin (25-4317) were purchased from eBioscience.”
Regulation of NF-κB-dependent T cell activation and development by MEKK3
Shinohara, H., Yamasaki, S., Maeda, S., Saito, T., & Kurosaki, T. (2009) · International Immunology · doi:10.1093/intimm/dxp007 · Cited by 17
Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases
Zhang, Y., Peng, J., & Luo, X. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114977 · Cited by 20
Kinase-Independent Feedback of the TAK1/TAB1 Complex on BCL10 Turnover and NF-κB Activation
Moreno‐García, M. E., Sommer, K., Rincón‐Arano, H., Brault, M., Ninomiya‐Tsuji, J., Matesic, L. E., & Rawlings, D. J. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.06407-11 · Cited by 17
“Two important targets of antigen receptors, NF- B and Jun N-terminal kinase (JNK), are activated downstream of CARMA1, a scaffolding protein that nucleates a complex including BCL10, MALT1, and other I B kinase (IKK)-signalosome components.”
BackgroundTargeting pathogenic mechanisms in marginal zone lymphoma: from concepts and beyond
Lue, J. K., O’Connor, O. A., & Bertoni, F. (2020) · Annals of Lymphoma · doi:10.21037/aol-20-20 · Cited by 15
“21037/aol-20-20 protein kinase Cβ (PKCβ) is activated by the increase in calcium and DAG, and induces the phosphorylation of CARD11, leading to the formation of the CBM complex (CARD11-BCL10-MALT1), triggering the downstream activation of NF-κB, which is critical in the development and sustainment of MZL cells (31).”
BackgroundPeddibhotla, S., Shi, R., Khan, P. M., Smith, L. H., Mangravita-Novo, A., Vicchiarelli, M., Su, Y., Okolotowicz, K. J., Cashman, J. R., Reed, J. C., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1000248 · Cited by 16
BCL10 is recruited to sites of DNA damage to facilitate DNA double-strand break repair
Ismail, I. H., Dronyk, A., Hu, X., Hendzel, M. J., & Shaw, A. R. (2016) · Cell Cycle · doi:10.1080/15384101.2015.1121322 · Cited by 16
“In the cytosol, BCL10 forms a complex with MALT1 and CARMA1 that functions to stimulate the immune response triggered by T/B-cell antigen receptors.(36) However, several research groups have reported that BCL10 nuclear expression correlates with a significant decrease in patient survival in primary cutaneous marginal…”
BackgroundZhu, D., Cheng, F., He, W., Wu, C., Li, X., & Wu, J. (2019) · Journal of Oncology · doi:10.1155/2019/9832956 · Cited by 16
“3.5. miR-181a Inhibits ABC-DLBCL Tumorigenesis by Suppressing CARD11.”
BackgroundInfluentialMerzianu, M., Jiang, L., Lin, P., Wang, X., Weber, D. M., Vadhan‐Raj, S., Nguyen, M. H., Medeiros, L. J., & Bueso-Ramos, C. (2006) · Modern Pathology · doi:10.1038/modpathol.3800609 · Cited by 16
“BCL-10 is a proapoptic gene in vitro with a role in lymphocyte maturation, differentiation, and activation”
BackgroundDevelopment and Function of B Cell Subsets
Vale, A. M., Kearney, J. F., Nóbrega, A., & Schroeder, H. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397933-9.00007-2 · Cited by 35
MALT1 Inhibitors and Degraders: Strategies for NF-κB-Driven Malignancies
Zhang, R., Wang, Z., Zhang, M., Wang, Y.-F., Zhou, S.-L., Xu, J.-L., Lin, W., Ji, T.-R., Chen, Y., Lu, T., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02873 · Cited by 17
The layered development of mouse B and T Cells
Montecino‐Rodriguez, E., & Dorshkind, K. A. (2022) · Immunological Reviews · doi:10.1111/imr.13181 · Cited by 18
Effective T-cell immune responses in the absence of the serine/threonine kinase RIP2
Nembrini, C., Reissmann, R., Köpf, M., & Marsland, B. J. (2008) · Microbes and Infection · doi:10.1016/j.micinf.2008.01.016 · Cited by 15
Srivastava, R., Burbach, B. J., Mitchell, J. S., Pagán, A. J., & Shimizu, Y. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06541-11 · Cited by 15
“These inducible interactions facilitate the formation of the CARMA1Bcl10-Malt1 (CBM) complex and the assembly of the protein kinase C (PKC ) signalosome that are required for optimal T cell receptor-mediated activation of NF- B (42).”
BackgroundImmune-Related Gene Expression Patterns in GPV- or H9N2-Infected Goose Spleens
Chen, S., Wang, A., Sun, L., Liu, F., Wang, M., Jia, R., Zhu, D., Liu, M., Yang, Q., Wu, Y., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17121990 · Cited by 16
“Moreover, the two proteins played an essential role in the development of lymphocytes and the effector function of mature lymphocytes [15].”
BackgroundShi, R., Ré, D., Dudl, E. P., Cuddy, M., Okolotowicz, K. J., Dahl, R. S., Su, Y., Hurder, A., Kitada, S., Peddibhotla, S., et al. (2010) · ACS Chemical Biology · doi:10.1021/cb9003089 · Cited by 16
“In T- and B-cells, this pathway is initiated by protein kinase C (PKC)- and PKC- , respectively, leading ultimately to IKK activation through a mechanism possibly involving lysine 63-linked polyubiquitination of IKK(12).”
Dynamic cycling of t-SNARE acylation regulates platelet exocytosis
Zhang, J., Huang, Y., Chen, J., Zhu, H., & Whiteheart, S. W. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000140 · Cited by 15
“IKK/SNAP-23 association and SNAP-23 phosphorylation occur in rafts (51) as does the formation of ternary SNARE complexes (52) IKK is also found in the rafts of T cells (53).”
BackgroundQiao, G., Li, Z., Minto, A. W., Shia, J., Yang, L., Bao, L., Tschopp, J., Gao, J.-X., Wang, J., Quigg, R. J., et al. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.143 · Cited by 15
“However, c-FLIPL-mediated inhibition of NF-kB activation in the thymus remains to be further determined, as deficiency for caspase-8, CARMA-1, Bcl-10, and MALT-1 does not perturb thymic selection.(37,38) It has been documented that c-FLIPL inhibits FasL-induced cell death.”
BackgroundStefan, C. P., Arnold, C. E., Shoemaker, C. J., Zumbrun, E. E., Altamura, L. A., Douglas, C. E., Taylor-Howell, C. L., Graham, A. S., Delp, K. L., Blancett, C. D., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9030665 · Cited by 15
Supramolecular organizing centers (SMOCs) as signaling machines in innate immune activation
Qiao, Q., & Wu, H. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4951-z · Cited by 15
Monajemi, M., Pang, Y. C. F., Bjornson, S., Menzies, S. C., van Rooijen, N., & Sly, L. M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3vma0118-019r · Cited by 15
Nore1B regulates TCR signaling via Ras and Carma1
Ishiguro, K., Avruch, J., Landry, A. L., Qin, S., Ando, T., Goto, H., & Xavier, R. J. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.01.015 · Cited by 18
Interaction of calmodulin with Bcl10 modulates NF-κB activation
Edin, S., Oruganti, S. R., Grundström, C., & Grundström, T. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.04.005 · Cited by 14
Weiser, K. C., Liu, B., Hansen, G. M., Skapura, D. G., Hentges, K. E., Yarlagadda, S. P., Morse, H. C., & Justice, M. J. (2007) · Mammalian Genome · doi:10.1007/s00335-007-9060-2 · Cited by 14
Lyu, A., Nam, S. H., Humphrey, R. S., Horton, T. M., & Ehrlich, L. I. R. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01335-7 · Cited by 18
Jang, T.-H., Park, J. H., & Park, H. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079778 · Cited by 13
L-CBM signaling in lymphocyte development and function
Hara, Iizasa, E., Nakaya, & Yoshida (2010) · Journal of Blood Medicine · doi:10.2147/jbm.s9772 · Cited by 13
Gloria, Y. C., Bernhart, S. H., Fillinger, S., Wolz, O., Dickhöfer, S., Admard, J., Ossowski, S., Nahnsen, S., Siebert, R., & Weber, A. N. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.616451 · Cited by 13
Selective benzimidazole inhibitors of the antigen receptor-mediated NF-κB activation pathway
Okolotowicz, K. J., Shi, R., Zheng, X., MacDonald, M., Reed, J. C., & Cashman, J. R. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.01.039 · Cited by 13
T-helper cells flexibility: the possibility of reprogramming T cells fate
Khantakova, J. N., & Sennikov, S. V. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1284178 · Cited by 14
Mo, Z., Han, Q., Zeng, Y.-L., Wang, J.-L., Li, X.-Z., Li, Y., Sun, H., Li, A., Luo, X., & Dan, X. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.03.039 · Cited by 13
Li, Y., Huang, S., Huang, X., Li, X., Falcon, A., Soutar, A., Bornancin, F., Jiang, Z., Xin, H.-B., & Fu, M. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.05.009 · Cited by 12
Axotomy-Induced Changes of the Protein Profile in the Crayfish Ventral Cord Ganglia
Demyanenko, S. V., Dzreyan, V., & Uzdensky, A. B. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01329-5 · Cited by 14
Dlgh1 and Carma1 MAGUK proteins contribute to signal specificity downstream of TCR activation
Rebeaud, F., Hailfinger, S., & Thome, M. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.03.004 · Cited by 14
Self-citationc‐Rel phenocopies PKCθ but not Bcl‐10 in regulating CD8+ T‐cell activation versus tolerance
Deenick, E. K., Po, L. K., Chapatte, L., Murakami, K., Lu, Y., Elford, A. R., Saibil, S. D., Ruland, J., Gerondakis, S., Mak, T. W., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200939445 · Cited by 14
Bertoni, F., Rossi, D., Raderer, M., & Zucca, E. (2020) · The Cancer Journal · doi:10.1097/ppo.0000000000000463 · Cited by 12
Kong, G., Dou, Y., Xiao, X., Wang, Y., Ming, Y., & Li, X. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.682220 · Cited by 11
Nuclear Factor 3B Activation and Antiapoptosis in Mucosa-Associated Lymphoid Tissue Lymphoma
Hosokawa, Y., & Seto, M. (2004) · International Journal of Hematology · doi:10.1532/ijh97.04101 · Cited by 11
BCL10 Expression in Ocular Adnexal Lymphomas
Curry, C. V., Harris, G. J., Erickson, B. A., Nishino, H., Chévez‐Barrios, P., & Chang, C.-C. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.05.038 · Cited by 11
BCL10 loss-of-function novel mutation leading to atypical severe combined immunodeficiency
Al-Tamemi, S., Alhinai, Z., Al-Rahbi, N., Al-Abdawani, R., Al-Yazidi, L., Al-Shekaili, J., Al-Kindi, M., & Al-Maawali, A. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109067 · Cited by 11
Dustin, M. L. (2011) · Nature Immunology · doi:10.1038/ni.2141 · Cited by 10
The NF-κB signalling pathway: a therapeutic target in lymphoid malignancies?
Stoffel, A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.1045 · Cited by 12
“These studies suggest that constitutive NF-κB activation by BCL10 overexpression may lead to abnormal cell proliferation/survival and malignant transformation [69,70].”
BackgroundRosebeck, S., Lim, M. S., Elenitoba-Johnson, K. S. J., McAllister-Lucas, L. M., & Lucas, P. C. (2016) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v7.i1.128 · Cited by 11
CK2β-regulated signaling controls B cell differentiation and function
Tubi, L. Q., Mandato, E., Nunes, S. C., Arjomand, A., Zaffino, F., Manni, S., Casellato, A., Macaccaro, P., Vitulo, N., Zumerle, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.959138 · Cited by 10
Ussat, S., Scherer, G., Fazio, J., Beetz, S., Kabelitz, D., & Adam‐Klages, S. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02449.x · Cited by 9
Targeting BCL10 by small peptides for the treatment of B cell lymphoma
Bao, W., Sun, C., Sun, X., He, M., Yu, H., Yan, W., Wen, F., Zhang, L., & Yang, C. (2020) · Theranostics · doi:10.7150/thno.47533 · Cited by 9
“Importantly, the depletion of BCL10 in mice or humans is not lethal but leads to defects in immune responses [20-25].”
BackgroundCARMA3: A potential therapeutic target in non-cancer diseases
Gui, Z., Zhang, Y., Zhang, A., Xia, W., & Jia, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1057980 · Cited by 10
Metadata
- Authors
- Thome, M.
- Affiliations
- University of Lausanne (CH)
- Corresponding author
- Thome, Margot
- ORCID
- Thome, Margot
- Venue
- Nature Reviews Immunology
- Published
- 2004-05
- Volume
- 4
- Issue
- 5
- Pages
- 348-359
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2018705412
- Cited by
- 391
- References
- 114
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 5 · 2023: 8 · 2022: 5 · 2021: 11 · 2020: 8 · 2019: 12 · 2018: 17 · 2017: 8 · 2016: 18 · 2015: 8 · 2014: 16 · 2013: 19 · 2012: 20
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Oncosuisse
- Krebsliga Schweiz
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- CARMA1, BCL10, MALT1, NF-κB signaling, lymphocyte development, B cell development, T cell development, lipopolysaccharide, B cell activation
- MeSH terms
- B-Cell CLL-Lymphoma 10 Protein, Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein, Animals, B-Lymphocytes, Carrier Proteins, Guanylate Cyclase, Humans, Lymphocyte Activation, Membrane Proteins, Neoplasm Proteins, T-Lymphocytes, Signal Transduction, NF-kappa B, Mice, Knockout, Lymphoma, B-Cell, Marginal Zone, Caspases, Adaptor Proteins, Signal Transducing, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.